2023 Q2 Form 10-Q Financial Statement

#000143462123000007 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $182.5M $200.5M $202.1M
YoY Change -30.34% -29.19% -21.77%
Cost Of Revenue $9.302M $13.76M $13.53M
YoY Change -36.17% -11.57% -6.36%
Gross Profit $173.2M $79.96M $188.5M
YoY Change 84.66% -19.61% -22.68%
Gross Profit Margin 94.9% 39.88% 93.3%
Selling, General & Admin $145.2M $173.8M $173.2M
YoY Change -35.41% -27.63% -22.45%
% of Gross Profit 83.87% 217.36% 91.89%
Research & Development $10.60M $14.66M $13.14M
YoY Change -25.96% 4.29% -4.25%
% of Gross Profit 6.12% 18.33% 6.97%
Depreciation & Amortization $6.666M $4.795M $8.803M
YoY Change 36.15% -1.22% -40.16%
% of Gross Profit 3.85% 6.0% 4.67%
Operating Expenses $162.5M $188.4M $195.2M
YoY Change -32.05% -25.86% -22.49%
Operating Profit $10.66M -$13.01M -$6.661M
YoY Change -373.73% 343.46% -16.64%
Interest Expense -$6.940M $25.03M -$6.024M
YoY Change 2.59% -433.5% -59.8%
% of Operating Profit -65.11%
Other Income/Expense, Net $1.879M $1.834M $2.037M
YoY Change 561.62% -183500.0% -97.55%
Pretax Income $112.0K $13.85M -$11.34M
YoY Change -101.08% -232.68% -118.84%
Income Tax $227.0K $395.0K -$937.0K
% Of Pretax Income 202.68% 2.85%
Net Earnings -$115.0K $13.46M -$10.40M
YoY Change -98.57% -224.3% -121.71%
Net Earnings / Revenue -0.06% 6.71% -5.15%
Basic Earnings Per Share -$0.01 $1.05
Diluted Earnings Per Share -$0.01 $1.04 -$0.81
COMMON SHARES
Basic Shares Outstanding 12.91M shares 12.81M shares 12.79M shares
Diluted Shares Outstanding 12.92M shares 12.94M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.6M $150.1M $298.8M
YoY Change -41.73% -23.69% 18.95%
Cash & Equivalents $162.6M $150.1M $298.8M
Short-Term Investments
Other Short-Term Assets $12.58M $28.27M $32.06M
YoY Change -54.33% 4.24% 25.79%
Inventory
Prepaid Expenses
Receivables $89.21M $83.66M $83.06M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $264.4M $262.0M $414.0M
YoY Change -37.35% -22.5% 10.57%
LONG-TERM ASSETS
Property, Plant & Equipment $121.0M $57.41M $59.16M
YoY Change 77.07% -18.77% -18.37%
Goodwill $420.1M $420.1M $420.1M
YoY Change 0.0% 0.0% 0.0%
Intangibles $54.28M $56.27M $58.32M
YoY Change -23.3% -27.72% -32.0%
Long-Term Investments $173.1M $174.6M $174.6M
YoY Change -0.82% 0.83% 10.4%
Other Assets $6.182M $6.319M $6.101M
YoY Change -7.63% -9.33% -12.11%
Total Long-Term Assets $774.7M $780.3M $785.3M
YoY Change -17.76% -17.99% -15.1%
TOTAL ASSETS
Total Short-Term Assets $264.4M $262.0M $414.0M
Total Long-Term Assets $774.7M $780.3M $785.3M
Total Assets $1.039B $1.042B $1.199B
YoY Change -23.82% -19.17% -7.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.174M $4.473M $2.030M
YoY Change -59.57% -54.86% 19.98%
Accrued Expenses $66.75M $84.83M $75.10M
YoY Change -29.69% -21.37% -29.64%
Deferred Revenue $1.000M $900.0K
YoY Change 0.0% 12.5%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $2.500M $2.500M
YoY Change 0.36% -98.52% -98.49%
Total Short-Term Liabilities $79.88M $91.80M $82.53M
YoY Change -24.12% -68.04% -69.93%
LONG-TERM LIABILITIES
Long-Term Debt $625.2M $625.4M $813.5M
YoY Change -23.12% 10.84% 70.14%
Other Long-Term Liabilities $84.94M $329.0K $308.0K
YoY Change 30674.28% -3.52% -12.25%
Total Long-Term Liabilities $710.2M $625.7M $813.8M
YoY Change -12.7% 10.83% 70.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.88M $91.80M $82.53M
Total Long-Term Liabilities $710.2M $625.7M $813.8M
Total Liabilities $797.4M $811.3M $991.4M
YoY Change -21.33% -14.47% 16.45%
SHAREHOLDERS EQUITY
Retained Earnings -$702.0M -$701.8M -$715.3M
YoY Change 28.51% 33.09% 25.1%
Common Stock $1.210B $1.199B $1.189B
YoY Change 4.04% 5.81% -4.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $266.2M $266.2M $266.2M
YoY Change 0.0% 0.0% 19.27%
Treasury Stock Shares 3.355M shares 3.355M shares
Shareholders Equity $241.7M $231.0M $207.9M
YoY Change
Total Liabilities & Shareholders Equity $1.039B $1.042B $1.199B
YoY Change -23.82% -19.17% -7.7%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$115.0K $13.46M -$10.40M
YoY Change -98.57% -224.3% -121.71%
Depreciation, Depletion And Amortization $6.666M $4.795M $8.803M
YoY Change 36.15% -1.22% -40.16%
Cash From Operating Activities $15.07M $13.16M $16.65M
YoY Change 147.26% 31.57% -60.7%
INVESTING ACTIVITIES
Capital Expenditures $2.401M $2.452M $2.473M
YoY Change -183.34% -170.76% -154.35%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $7.000K
YoY Change -100.0% -100.0% -99.98%
Cash From Investing Activities -$2.401M -$2.452M -$2.466M
YoY Change -44.43% -86.72% -105.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K -$159.6M -875.0K
YoY Change -100.12% 246.14% -98.18%
NET CHANGE
Cash From Operating Activities 15.07M $13.16M 16.65M
Cash From Investing Activities -2.401M -$2.452M -2.466M
Cash From Financing Activities -100.0K -$159.6M -875.0K
Net Change In Cash 12.57M -$148.9M 13.30M
YoY Change -84.76% 130.57% -63.0%
FREE CASH FLOW
Cash From Operating Activities $15.07M $13.16M $16.65M
Capital Expenditures $2.401M $2.452M $2.473M
Free Cash Flow $12.67M $10.70M $14.17M
YoY Change 41.14% -20.5% -69.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434621
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34063
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LendingTree, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2414818
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1415 Vantage Park Dr.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28203
CY2023Q1 dei City Area Code
CityAreaCode
704
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
541-5351
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
TREE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12910742 shares
CY2023Q1 us-gaap Revenues
Revenues
200508000 usd
CY2022Q1 us-gaap Revenues
Revenues
283178000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
13760000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
15561000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
137111000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
204157000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36683000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35977000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14655000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14052000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4795000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4854000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7917000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4454000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
3625000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12000 usd
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
27000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
213519000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
286116000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13011000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2938000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25029000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7505000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1834000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13852000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10444000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10826000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10826000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12846000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12901000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12935000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12901000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150074000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
34000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2688000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83662000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83060000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28231000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26250000 usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5689000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
262001000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
413968000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34925000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33851000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57411000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59160000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65578000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
67050000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
420139000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56266000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
174580000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
174580000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6319000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6101000 usd
CY2023Q1 us-gaap Assets
Assets
1042294000 usd
CY2022Q4 us-gaap Assets
Assets
1199313000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4473000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2030000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84829000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75095000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2909000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
91802000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82534000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
625356000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
813516000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86685000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88232000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7143000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6783000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
329000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
308000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
811315000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
991373000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16265177 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16167184 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12909711 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12811718 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
163000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
162000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1198836000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1189255000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701842000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715299000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3355466 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3355466 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
230979000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
207940000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1042294000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1199313000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
207940000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11274000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1693000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
230979000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447992000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10826000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10826000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15080000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
43009000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3086000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
340848000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10826000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5027000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-431000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7917000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4795000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
4854000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11274000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15080000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
360000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
326000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
963000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
850000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1959000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2467000 usd
CY2023Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2373000 usd
CY2022Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
879000 usd
CY2023Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-877000 usd
CY2022Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-49000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
34308000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
211000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17488000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1882000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3666000 usd
CY2023Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
8559000 usd
CY2022Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
9322000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
42000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
48000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
424000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
146000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13156000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9999000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2452000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3465000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
15000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2452000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18465000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
625000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
CY2023Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-1693000 usd
CY2022Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-3085000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
43009000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
156294000 usd
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
953000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-159565000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46098000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-148861000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-54564000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298969000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251342000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150108000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196778000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the impact of the current economic conditions, including interest rates, inflation, and the COVID-19 pandemic on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional </span></div>information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Risks and Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and credit card fraud.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk at March 31, 2023, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div>
CY2022Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
200000 usd
CY2023Q1 us-gaap Revenues
Revenues
200508000 usd
CY2022Q1 us-gaap Revenues
Revenues
283178000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13400000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12200000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
900000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
700000 usd
CY2023Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
200000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150074000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
34000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150108000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298969000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1456000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
963000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
850000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
963000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
503000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023Q1 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
371000 usd
CY2022Q1 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2688000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1803000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46124000 usd
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
420139000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46124000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56266000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86400000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40276000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46124000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
87400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39227000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5646000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5889000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5830000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5504000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5198000 usd
CY2023Q1 tree Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
18057000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2100000 usd
CY2023Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1700000 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
400000 usd
CY2023Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
44222000 usd
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
37703000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9398000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11444000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1539000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1393000 usd
CY2023Q1 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7253000 usd
CY2022Q4 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7273000 usd
CY2023Q1 tree Charitable Contribution Accrual
CharitableContributionAccrual
0 usd
CY2022Q4 tree Charitable Contribution Accrual
CharitableContributionAccrual
500000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8901000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8513000 usd
CY2023Q1 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
4446000 usd
CY2022Q4 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
304000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9070000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7965000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84829000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75095000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12846000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12901000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
35000 shares
CY2022Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12935000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12901000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
379895 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
96700000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11274000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15080000 usd
CY2023Q1 us-gaap Share Price
SharePrice
26.66
CY2023Q1 us-gaap Share Price
SharePrice
26.66
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.037
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
2500000 usd
CY2023Q1 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
395000 usd
CY2022Q1 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-2086000 usd
CY2023Q1 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
0 usd
CY2022Q1 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
2468000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000 usd
CY2023Q1 us-gaap Revenues
Revenues
200508000 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
120551000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2023Q1 us-gaap Litigation Reserve
LitigationReserve
200000 usd
CY2022Q4 us-gaap Litigation Reserve
LitigationReserve
100000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q1 us-gaap Gross Profit
GrossProfit
79957000 usd
CY2023Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
13760000 usd
CY2023Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
16560000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36683000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14655000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4795000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4454000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13011000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25029000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1834000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13852000 usd
CY2022Q1 us-gaap Revenues
Revenues
283178000 usd
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
183714000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
99464000 usd
CY2022Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
15561000 usd
CY2022Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
20443000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35977000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14052000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4854000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7917000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
3625000 usd
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
27000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2938000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7505000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10444000 usd

Files In Submission

Name View Source Status
0001434621-23-000007-index-headers.html Edgar Link pending
0001434621-23-000007-index.html Edgar Link pending
0001434621-23-000007.txt Edgar Link pending
0001434621-23-000007-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tree-20230331_lab.xml Edgar Link unprocessable
tree-20230331_pre.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tree-20230331.htm Edgar Link pending
tree-20230331.xsd Edgar Link pending
tree-20230331_g1.jpg Edgar Link pending
tree-20230331_g2.jpg Edgar Link pending
tree-2023331x10qexx311.htm Edgar Link pending
tree-2023331x10qexx312.htm Edgar Link pending
tree-2023331x10qexx321.htm Edgar Link pending
tree-2023331x10qexx322.htm Edgar Link pending
tree-20230331_cal.xml Edgar Link unprocessable
tree-20230331_htm.xml Edgar Link completed
tree-20230331_def.xml Edgar Link unprocessable